BY DOYIN OJOSIPE
Following an outbreak of Lasa Fever in Lagos State, the Nigeria Center for Disease Control (NCDC) today disclosed that contact identification and tracing has been initiated and case management has begun for other confirmed cases.
It also said that the federal government has provided resources including medical supplies to support case management in the State.
Two persons have been reportedly killed and a doctor infected at the Lagos University Teaching Hospital (LUTH).
It’s about the 49th week of the disease breakout in the country and 113 deaths have been recorded while a total of 689 suspected cases have been reported as at 31st week of 2017, the NCDC has revealed.
The NCDC in a press release has therefore advise Nigerians to be more vigilant, maintaining good hygiene, keeping away of food items from rodents, regular washing of hands and not hesitating to report any suspected case to the Center, using the tool free lines: 0800-970000-10 SMS 08099555577 Whatsapp 07087110839. Twitter/Facebook: @NCDCgov.
It also noted that although there is no known vaccine for the treatment of the disease, it could be managed, treated and better still avoided.
The NCDC has further advised healthcare givers to practice universal care precautions while attending to patients and also be observant of the disease should cases of common fever including Malaria is ruled out.
According to the statement, “Lassa fever is a viral hemorrhagic illness, caused by contact with food or household items contaminated with rodent urine or faeces. The Lassa virus may also be spread between humans through direct contact with blood, urine, faeces, or other bodily secretions of a person infected with Lassa fever.
“The illness is characterized by sudden onset of fever, and general weakness. Other symptoms including headache, sore throat, muscle pain, chest pain, nausea, vomiting, diarrhoea, cough, and abdominal pain may follow. In the most severe cases, individuals may bleed from the mouth, nose, eyes or other parts of the body.
All rights reserved. This material, and other digital content on this website, may not be reproduced, published, broadcast, rewritten or redistributed in whole or in part without prior express written permission from LEADERSHIP. Contact: [email protected]
Sign up for our newsletter